These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease. Helley MP; Pinnell J; Sportelli C; Tieu K Front Genet; 2017; 8():177. PubMed ID: 29204154 [TBL] [Abstract][Full Text] [Related]
8. Eye Movements in Parkinson's Disease and Inherited Parkinsonian Syndromes. Pretegiani E; Optican LM Front Neurol; 2017; 8():592. PubMed ID: 29170650 [TBL] [Abstract][Full Text] [Related]
10. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders. Palin EJ; Paetau A; Suomalainen A Brain; 2013 Aug; 136(Pt 8):2379-92. PubMed ID: 23811324 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease. Giannoccaro MP; La Morgia C; Rizzo G; Carelli V Mov Disord; 2017 Mar; 32(3):346-363. PubMed ID: 28251677 [TBL] [Abstract][Full Text] [Related]
12. Sphingolipids in the Pathogenesis of Parkinson's Disease and Parkinsonism. Lin G; Wang L; Marcogliese PC; Bellen HJ Trends Endocrinol Metab; 2019 Feb; 30(2):106-117. PubMed ID: 30528460 [TBL] [Abstract][Full Text] [Related]
13. Inherited metabolic disorders involving the eye: a clinico-biochemical perspective. Rajappa M; Goyal A; Kaur J Eye (Lond); 2010 Apr; 24(4):507-18. PubMed ID: 19798114 [TBL] [Abstract][Full Text] [Related]